Therapeutic options for perioperatively acquired platelet dysfunctions;Therapieoptionender perioperativ erworbenen thrombozytopathie

Anaesthesist

Volumn 58, Issue 9, 2009, Pages 931-940

  Weber, C F ^a   Schneider, A C ^a   Kirschning, T ^c   Hofstetter, C ^a   Zacharowski, K ^a   Gorlinger K ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Desmopressin; Platelet dysfunction; Platelet transfusion; Preconditions of haemostasis; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ARGIPRESSIN[1 DEAMINO]; BLOOD CLOTTING FACTOR 7A; FIBRINOGEN; RECOMBINANT PROTEIN; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING PARAMETERS; HEMOSTASIS; HUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; PERIOPERATIVE PERIOD; REVIEW; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD PLATELET DISORDERS; DEAMINO ARGININE VASOPRESSIN; FACTOR VIIA; FIBRINOGEN; HEMOSTASIS; HUMANS; MONITORING, INTRAOPERATIVE; PERIOPERATIVE CARE; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; TRANEXAMIC ACID;

EID: 77950511785     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-009-1599-8     Document Type: Article

References (83)

1. Amitrano L, Guardascione MA, Brancaccio V et al (2002) Coagulation disorders in liver disease. Semin Liver Dis 22:83-96 (Pubitemid 34225974)
2. Ang L, Palakodeti V, Khalid A et al (2008) Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coll Cardiol 52:1052-1059
3. Astedt B (1987) Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl 137:22-25
4. Beck KH, Mohr P, Bleckmann U et al (1995) Desmopressin effect on acetylsalicylic acid impaired platelet function. Semin Thromb Hemost 21 [Suppl 2]:32-39
5. Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929
6. Braine HG, Kickler TS, Charache P et al (1986) Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 26:391-393 (Pubitemid 16056287)
7. Bundesärztekammer (2008) Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, 4. Aufl. Deutscher Ärzte-Verlag, Köln
8. Burger R, Offergeld R (2008) Festlegung der Haltbarkeitsfrist von Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontamination. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 51:1484
9. Carless PA, Henry DA, Moxey AJ et al (2004) Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev: CD001884
10. Cattaneo M (2002) Desmopressin in the treatment of patients with defects of platelet function. Haematologica 87:1122-1124
11. Cattaneo M, Pareti FI, Zighetti M et al (1995) Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time. J Lab Clin Med 125:540-547
12. Cauwenberghs S, Van Pampus E, Curvers J et al (2007) Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 21:287-294 (Pubitemid 47444515)
13. De Haan J, Van Oeveren W (1998) Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin. Thromb Res 92:171-179 (Pubitemid 28541063)
14. De Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29:1261-1267 (Pubitemid 32554345)
15. Despotis GJ, Avidan MS, Hogue CW Jr (2001) Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72:S1821-S1831 (Pubitemid 33049834)
16. Despotis GJ, Levine V, Saleem R et al (1999) Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet 354:106-110 (Pubitemid 29313144)
17. Deusch E, Thaler U, Kozek-Langenecker SA (2004) The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 99:665-668 (Pubitemid 39100348)
18. Dowd NP, Karski JM, Cheng DC et al (2002) Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 97:390-399 (Pubitemid 34847752)
19. Eugster M, Reinhart WH (2005) The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 94:1213-1218 (Pubitemid 41819618)
20. Flordal PA (1998) Use of desmopressin to prevent bleeding in surgery. Eur J Surg 164:5-11
21. Franz A, Braunlich P, Gamsjager T et al (2001) The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 92:1402-1407 (Pubitemid 32493149)
22. Furtmuller R, Schlag MG, Berger M et al (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 301:168-173 (Pubitemid 34256345)
23. Görlinger K (2006) Coagulation management in liver transplantation. Hamostaseologie 26:64-76
24. Görlinger K (2008) Ist der Einsatz von Point-of-Care zur Gerinnungsdiagnostik effizient? In: Kuhlen R, Putensen C, Quintel M (Hrsg) Interdisziplinäre Intensivmedizin Aktuell, Bd 1. MEPS, Nürnberg, S 249-266
25. Görlinger K, Jámbor C, Hanke A et al (2007) Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 34:396-411 (Pubitemid 350249146)
26. Hardy JF, De Moerloose P, Samama M (2004) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 51:293-310
27. Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360-365
28. Hirsh J, Guyatt G, Albers GW et al (2008) Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edn. Chest 133:71S-109S (Pubitemid 351892961)
29. Horne MK 3rd, Cullinane AM, Merryman PK et al (2006) The effect of red blood cells on thrombin generation. Br J Haematol 133:403-408
30. Ivert T, Intonti M, Stain-Malmgren R et al (1998) Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid. Scand Cardiovasc J 32:289-295 (Pubitemid 28510641)
31. Jámbor C, Weber C, Van Beesel K et al (2007) Monitoring of the efficacy of platelet transfusion in complex cardiac surgery - point of care evaluation with ROTEM and multiplate. Appl Cardiopulm Pathophysiol 11:68-69 (Pubitemid 351293003)
32. Karpman D, Manea M, Vaziri-Sani F et al (2006) Platelet activation in hemolytic uremic syndrome. Semin Thromb Hemost 32:128-145
33. Kermode JC, Zheng Q, Milner EP (1999) Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94:199-207 (Pubitemid 29300150)
34. Khan H, Belsher J, Yilmaz M et al (2007) Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131:1308-1314 (Pubitemid 46762333)
35. Koscielny J, Pruss A, Kiesewetter H (2005) Klinischer Einsatz von Desmopressin und Antifibrinolytika in der perioperativen Intensivmedizin. In: Intensivmedizin. ecomed Medizin, Landsberg, 15. Ergänzungslieferung Oktober 2005
36. Koscielny J, Ziemer S, Radtke H et al (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10:195-204 (Pubitemid 38982043)
37. Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103:654-660
38. Lang T, Johanning K, Metzler H et al (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 108:751-758
39. Lasne D, Jude B, Susen S (2006) From normal to pathological hemostasis. Can J Anaesth 53:S2-S11 (Pubitemid 44150880)
40. Lethagen S (1994) Desmopressin (DDAVP) and hemostasis. Ann Hematol 69:173-180
41. Levy JH (2008) Pharmacologic methods to reduce perioperative bleeding. Transfusion 48:31S-38S
42. Linnemann B, Schwonberg J, Mani H et al (2008) Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 6:677-683 (Pubitemid 351404936)
43. Lucas-Polomeni MM, Delaval Y, Menestret P et al (2004) A case of anaphylactic shock with tranexamic acid (Exacyl). Ann Fr Anesth Reanim 23:607-609 (Pubitemid 38987235)
44. Mahmud E, Cavendish JJ, Tsimikas S et al (2007) Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention. J Am Coll Cardiol 49:2163-2171 (Pubitemid 46817810)
45. Mannucci PM (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90:2515-2521
46. Mannucci PM, Ruggeri ZM, Pareti FI et al (1977) 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet 1:869-872 (Pubitemid 8079684)
47. Mcloughlin TM, Fontana JI, Alving B et al (1996) Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 83:459-465 (Pubitemid 26296348)
48. Mengistu AM, Rohm KD, Boldt J et al (2008) The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Anesth Analg 107:391-397
49. Michelson AD (2009) Methods for the measurement of platelet function. Am J Cardiol 103:20A-26A
50. Michelson AD, Macgregor H, Barnard MR et al (1994) Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 71:633-640 (Pubitemid 24132964)
51. Paparella D, Brister SJ, Buchanan MR (2004) Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30:1873-1881 (Pubitemid 39468407)
52. Pereboom IT, De Boer MT, Haagsma EB et al (2009) Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 108:1083-1091
53. Pereira A, Del Valle Onorato M, Sanz C (2003) DDAVP enhances the ability of blood monocytes to form rosettes with activated platelets by increasing the expression of P-selectin sialylated ligands on the monocyte surface. Br J Haematol 120:814-820 (Pubitemid 36315104)
54. Poon M, D'oiron R, Hann I (2001) Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 38:21-25
55. Poon M, Zotz R, Di Minno G (2006) Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Semin Hematol 43:33-36
56. Pruß A, Koscielny J, Latza R et al (1999) Diagnostik und Therapie der hämorrhagischen Diathese in der perioperativen Situation. Gefasschirurgie 4:5-12 (Pubitemid 29232444)
57. Rahe-Meyer N, Pichlmaier M, Haverich A et al (2009) Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 102:785-792
58. Rahe-Meyer N, Winterhalter M, Boden A et al (2009) Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 53:168-175
59. Rajagopalan S, Mascha E, Na J et al (2008) The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 108:71-77
60. Ray MJ, Marsh NA, Just SJ et al (1997) Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ann Thorac Surg 63:57-63 (Pubitemid 27039032)
61. Reiter RA, Mayr F, Blazicek H et al (2003) Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 102:4594-4599 (Pubitemid 37494129)
62. Rinder CS, Mathew JP, Rinder HM et al (1991) Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 75:563-570
63. Samama CM, Djoudi R, Lecompte T et al (2005) Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003. Can J Anaesth 52:30-37 (Pubitemid 40361016)
64. Scharf R (2003) Angeborene und erworbene Thrombozytenfunktionsstö rungen. Hamostaseologie 23:170-180
65. Schrezenmeier H, Walther-Wenke G, Muller TH et al (2007) Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47:644-652 (Pubitemid 46449625)
66. Schulman S (1991) DDAVP - the multipotent drug in patients with coagulopathies. Transfus Med Rev 5:132-144
67. Shepherd LL, Hutchinson RJ, Worden EK et al (1989) Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis. J Pediatr 114:470-472 (Pubitemid 19083833)
68. Sloand EM, Alyono D, Klein HG et al (1994) 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 46:199-207 (Pubitemid 24206745)
69. Sloand JA, Sloand EM (1997) Studies on platelet membrane glycoproteins and platelet function during hemodialysis. J Am Soc Nephrol 8:799-803 (Pubitemid 27493594)
70. Soslau G, Horrow J, Brodsky I (1991) Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 38:113-119
71. Spalding GJ, Hartrumpf M, Sierig T et al (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 31:1052-1057 (Pubitemid 46719967)
72. Spiess BD, Royston D, Levy JH et al (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44:1143-1148 (Pubitemid 38989746)
73. Valeri CR, Cassidy G, Pivacek LE et al (2001) Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41:977-983 (Pubitemid 33642786)
74. Valeri CR, Feingold H, Cassidy G et al (1987) Hypothermia-induced reversible platelet dysfunction. Ann Surg 205:175-181 (Pubitemid 17028630)
75. Van Oeveren W, Harder MP, Roozendaal KJ et al (1990) Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:788-796; discussion 796-787
76. Velik-Salchner C, Eschertzhuber S, Streif W et al (2008) Acquired von Willebrand syndrome in cardiac patients. J Cardiothorac Vasc Anesth 22:719-724
77. Velik-Salchner C, Haas T, Innerhofer P et al (2007) The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5:1019-1025 (Pubitemid 46691732)
78. Velik-Salchner C, Maier S, Innerhofer P et al (2009) An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg 108:1747-1754
79. Vincentelli A, Susen S, Le Tourneau T et al (2003) Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 349:343-349 (Pubitemid 36886240)
80. Voges I, Burstein C, Budde U et al (2006) Acquired von Willebrand syndrome in two children with congenital heart defects and abnormal haemodynamics. Hamostaseologie 26:345-348 (Pubitemid 44805172)
81. Weber C, Jambor C (2009) Platelet function before and after DDAVP therapy measured bedside by Multiple Electrode Aggregometry (MEA) correlates with blood loss in patients after cardiac surgery. Hamostaseologie 29:A55
82. Ying CL, Tsang SF, Ng KF (2008) The potential use of desmopressin to correct hypothermia-induced impairment of primary haemostasis - an in vitro study using PFA-100. Resuscitation 76:129-133 (Pubitemid 350245419)
83. Zotz R, Araba F, Bux I (2009) Desmopressin (DDAVP) for minimising perioperative allogenic blood transfusion: a stratified metaanalysis. Hamostaseologie 29:A53